Delivery Order SPE2DB20D6035-SPE2DB24FD2RG

Award Date 8/7/24
Potential Completion Date 8/8/24
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,456.56 firm fixed-price delivery order is for the supply of Cefpodoxime 200 mg tablets and has an ultimate completion date of January 16, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award is for the delivery of Cefpodoxime 100 mg tablets to the Defense Logistics Agency (DLA). The $1,198.85 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award has an ultimate completion date of May 13, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, as well as...
This federal contract award was made by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distribution company. The $1,241.95 Firm Fixed Price Delivery Order is for the supply of 4,564,662,187 units of the prescription drug Cefpodoxime 200 mg Tablets. The award has an ultimate completion date of May 21, 2024 and is not designated as a set-aside contract. AmerisourceBergen holds a larger Indefinite Delivery...
This federal contract award, valued at $2,156.40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CEFPODOXIME 200 MG TABLET 20S, a pharmaceutical product, with a period of performance through February 20, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Cefpodoxime 200 mg tablets. The contract has a firm fixed price of $6,967.65 and a completion date of September 27, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical for delivering a range of medical commodities to support military...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,530.68 firm fixed-price delivery order is for the supply of 4,567,859,134 units of the pharmaceutical product CEFPODOXIME 200 MG TABLET 20S. The contract has an ultimate completion date of April 10, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of Cefpodoxime 100mg/5ml suspension in 100ml bottles to the Defense Logistics Agency (DLA). The $2,418.80 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. The contract has an ultimate completion date of November 7, 2022 and was awarded on November 4, 2022. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,847.78 firm fixed-price delivery order is for the supply of 4562858177 - CEFPODOXIME 200 MG TABLET 20S, with a completion date of November 20, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, running through November 2026. This IDC...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,567,300,894 units of the prescription drug Cefpodoxime 100 mg tablets. The $5,808.14 firm fixed-price contract has a completion date of February 19, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products...
This federal contract award, valued at $1,624.71, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of CEFPODOXIME 200 MG TABLET 20S, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of April 19, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
  • SPE2DB20D6035
    Indefinite Delivery Contract
  • SPE2DB20D6035-SPE2DB24FD2RG
    Delivery Order

This federal contract award, valued at $1,150.08, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Cefpodoxime 200 mg tablets. The award is a delivery order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which allows the agency to efficiently procure a wide range of medical commodities and prescription drugs to support military treatment programs and facilities worldwide. The contract has no set-aside designation and is set to expire on August 8, 2024. Amerisourcebergen has extensive experience supplying critical pharmaceutical and medical supplies to various federal agencies, including the Department of Justice Federal Bureau of Investigation, under similar IDC vehicles.

Generated 11/6/24, 9:03 AM